Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Oropharyngeal dysphagia in patients with multiple sclerosis: do the disease classification scales reflect dysphagia severity?
Functional brain networks: Linking thalamic atrophy to clinical disability in multiple sclerosis, a multimodal fMRI and MEG Study.
Cost-Effectiveness Analysis of Delayed-Release Dimethyl Fumarate for The Treatment of Relapsing Remitting Multiple Sclerosis In Spain.
TAM receptor tyrosine kinases: Expression, disease and oncogenesis in the central nervous system.
Synthesis of genistein coupled with sugar derivatives and their inhibitory effect on nitric oxide production in macrophages.
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa.
Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis.
The structure and function of the S1P1 receptor.
Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India.
Superior temporal gyrus thickness correlates with cognitive performance in multiple sclerosis.
Novel remyelination strategy for multiple sclerosis in the era of oligodendrocytopathy.
Cognitive and psychosocial issues in pediatric multiple sclerosis: where we are and where we need to go.
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study.
Steroid-responsive hearing impairment in NMO-IgG/aquaporin-4-antibody-positive neuromyelitis optica.
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS).
Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS.
Emotional and neutral verbal memory impairment in Multiple Sclerosis.
Erratum to: Promoting Remyelination in Multiple Sclerosis-Recent Advances.
Teriflunomide for the treatment of multiple sclerosis.
Cerebrospinal fluid myelin basic protein is frequently ordered but has little value: a test utilization study.
[Compensatory mechanisms in multiple sclerosis(review)].
Associations between Klinefelter's syndrome and autoimmune diseases: English national record linkage studies.
Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system.
Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis.
Information provision for people with multiple sclerosis.
Pages
« first
‹ previous
…
298
299
300
301
302
303
304
305
306
…
next ›
last »